The panic attack treatment market size has grown rapidly in recent years. It will grow from $3.58 billion in 2025 to $4.21 billion in 2026 at a compound annual growth rate (CAGR) of 17.6%. The growth in the historic period can be attributed to limited awareness of panic attack treatments, reliance on in-person therapy, high cost of specialized medications, fragmented mental healthcare infrastructure, low adoption of digital therapy tools.
The panic attack treatment market size is expected to see rapid growth in the next few years. It will grow to $7.97 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of telehealth platforms, growth in virtual reality and digital therapeutics, rising prevalence of anxiety and panic disorders, advancements in personalized medicine, expansion of online pharmacy and hospital distribution channels. Major trends in the forecast period include rising adoption of telepsychiatry and mobile health applications, integration of virtual reality therapy for panic disorders, increasing use of neurofeedback and biofeedback techniques, growth in personalized medication plans, expansion of mental healthcare centers and hospital services.
The rising prevalence of anxiety is expected to drive growth in the panic attack treatment market going forward. Anxiety is a mental health disorder characterized by persistent feelings of worry, fear, and nervousness, often accompanied by physical symptoms such as rapid heartbeat, restlessness, and difficulty concentrating. Modern life contributes to increasing anxiety levels through constant demands for productivity, financial security, and social performance, leaving limited time for emotional recovery. Panic attack treatments address anxiety by providing effective interventions that alleviate symptoms, improve emotional well-being, and help individuals regain control over their lives through timely and personalized care. For instance, in May 2024, the American Psychiatric Association (APA), a US-based medical specialty society representing psychiatrists, reported that 43% of U.S. adults experienced higher anxiety levels in 2024, compared to 37% in 2023 and 32% in 2022. Therefore, the growing prevalence of anxiety is driving the panic attack treatment market.
Companies in this market are focusing on technological advancements such as digital anxiety relief platforms to enhance the management of panic attacks and anxiety through accessible, data-driven solutions. Digital anxiety relief platforms use technology to provide interventions including guided meditation, cognitive behavioral therapy modules, mood tracking, and relaxation exercises. For instance, in October 2024, CalmiGo, a US-based mental health startup, launched CalmiGo Plus, an advanced digital platform combining a patented sensor-based exhaler with a companion mobile app. This platform leverages gamification and personalized therapeutic techniques to provide immediate, drug-free relief while tracking user progress, representing a significant step forward in accessible, technology-driven anxiety management.
In August 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired Cerevel Therapeutics for $8.7 billion. This acquisition enabled AbbVie to expand its neuroscience portfolio by integrating Cerevel’s pipeline of treatments for psychiatric and neurological disorders, including panic attacks and anxiety. Cerevel Therapeutics is a US-based clinical-stage biopharmaceutical company focused on developing innovative therapies for neuroscience-related conditions, particularly anxiety and panic disorders.
Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann‑La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol‑Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited.
North America was the largest region in the panic attack treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the panic attack treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the panic attack treatment market by increasing the cost of imported medications, neurofeedback devices, and virtual reality therapy systems. Hospital pharmacies, retail pharmacies, and mental healthcare centers in north america, europe, and asia-pacific are most affected due to their reliance on imported therapies and devices. While tariffs create cost pressures, they also encourage local production, foster innovation in telepsychiatry tools, and strengthen domestic availability of digital and therapeutic solutions.
The panic attack treatment market research report is one of a series of new reports that provides panic attack treatment market statistics, including panic attack treatment industry global market size, regional shares, competitors with a panic attack treatment market share, detailed panic attack treatment market segments, market trends and opportunities, and any further data you may need to thrive in the panic attack treatment industry. This panic attack treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Panic attack treatment involves medical and psychological interventions aimed at managing, reducing, and preventing sudden, intense episodes of fear or discomfort, which are accompanied by both physical and emotional distress. These treatments help restore emotional stability, reduce disruptions to daily life, and support long-term mental health for individuals experiencing panic-related disorders.
The main types of panic attack treatment include cognitive behavioral therapy (CBT), medications, and other approaches. CBT is a structured, time-limited psychotherapy that helps individuals recognize and modify negative thought patterns and behaviors that contribute to anxiety and panic episodes. Medications used include antidepressants, anti-anxiety drugs, calcitonin gene-related peptide (CGRP) antagonists, and others. These medications are administered via oral, intravenous, intramuscular, sublingual, and other routes, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. They are applied in settings such as hospitals, mental healthcare centers, and other healthcare facilities.
The panic attack treatment market consists of revenues earned by entities by providing services such as exposure therapy sessions, dialectical behavior therapy, telepsychiatry and remote consultation services, mental wellness subscription platforms, supportive counseling and peer group therapy, and personalized mental health coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic attack treatment market also includes sales of biofeedback and neurofeedback devices, virtual reality-based therapy solutions, mobile mental health applications, genetic testing kits for psychiatric profiling, mental health diagnostic and screening tools, wearable devices for anxiety monitoring, AI-powered therapeutic chatbots, and digital therapeutic platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The panic attack treatment market size is expected to see rapid growth in the next few years. It will grow to $7.97 billion in 2030 at a compound annual growth rate (CAGR) of 17.3%. The growth in the forecast period can be attributed to increasing adoption of telehealth platforms, growth in virtual reality and digital therapeutics, rising prevalence of anxiety and panic disorders, advancements in personalized medicine, expansion of online pharmacy and hospital distribution channels. Major trends in the forecast period include rising adoption of telepsychiatry and mobile health applications, integration of virtual reality therapy for panic disorders, increasing use of neurofeedback and biofeedback techniques, growth in personalized medication plans, expansion of mental healthcare centers and hospital services.
The rising prevalence of anxiety is expected to drive growth in the panic attack treatment market going forward. Anxiety is a mental health disorder characterized by persistent feelings of worry, fear, and nervousness, often accompanied by physical symptoms such as rapid heartbeat, restlessness, and difficulty concentrating. Modern life contributes to increasing anxiety levels through constant demands for productivity, financial security, and social performance, leaving limited time for emotional recovery. Panic attack treatments address anxiety by providing effective interventions that alleviate symptoms, improve emotional well-being, and help individuals regain control over their lives through timely and personalized care. For instance, in May 2024, the American Psychiatric Association (APA), a US-based medical specialty society representing psychiatrists, reported that 43% of U.S. adults experienced higher anxiety levels in 2024, compared to 37% in 2023 and 32% in 2022. Therefore, the growing prevalence of anxiety is driving the panic attack treatment market.
Companies in this market are focusing on technological advancements such as digital anxiety relief platforms to enhance the management of panic attacks and anxiety through accessible, data-driven solutions. Digital anxiety relief platforms use technology to provide interventions including guided meditation, cognitive behavioral therapy modules, mood tracking, and relaxation exercises. For instance, in October 2024, CalmiGo, a US-based mental health startup, launched CalmiGo Plus, an advanced digital platform combining a patented sensor-based exhaler with a companion mobile app. This platform leverages gamification and personalized therapeutic techniques to provide immediate, drug-free relief while tracking user progress, representing a significant step forward in accessible, technology-driven anxiety management.
In August 2024, AbbVie Inc., a US-based biopharmaceutical company, acquired Cerevel Therapeutics for $8.7 billion. This acquisition enabled AbbVie to expand its neuroscience portfolio by integrating Cerevel’s pipeline of treatments for psychiatric and neurological disorders, including panic attacks and anxiety. Cerevel Therapeutics is a US-based clinical-stage biopharmaceutical company focused on developing innovative therapies for neuroscience-related conditions, particularly anxiety and panic disorders.
Major companies operating in the panic attack treatment market are Pfizer Inc., Johnson & Johnson Services Inc., F. Hoffmann‑La Roche Ltd., Sanofi S.A., AstraZeneca Plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma, Lundbeck A/S, Torrent Pharmaceuticals Ltd., Merck & Co Inc., Bristol‑Myers Squibb Company, Otsuka Pharmaceutical Co Ltd, Boehringer Ingelheim International GmbH, Allergan plc, Alkermes plc, Jazz Pharmaceuticals plc, Bayer AG, Amgen Inc., Cipla Limited.
North America was the largest region in the panic attack treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the panic attack treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the panic attack treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs have influenced the panic attack treatment market by increasing the cost of imported medications, neurofeedback devices, and virtual reality therapy systems. Hospital pharmacies, retail pharmacies, and mental healthcare centers in north america, europe, and asia-pacific are most affected due to their reliance on imported therapies and devices. While tariffs create cost pressures, they also encourage local production, foster innovation in telepsychiatry tools, and strengthen domestic availability of digital and therapeutic solutions.
The panic attack treatment market research report is one of a series of new reports that provides panic attack treatment market statistics, including panic attack treatment industry global market size, regional shares, competitors with a panic attack treatment market share, detailed panic attack treatment market segments, market trends and opportunities, and any further data you may need to thrive in the panic attack treatment industry. This panic attack treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Panic attack treatment involves medical and psychological interventions aimed at managing, reducing, and preventing sudden, intense episodes of fear or discomfort, which are accompanied by both physical and emotional distress. These treatments help restore emotional stability, reduce disruptions to daily life, and support long-term mental health for individuals experiencing panic-related disorders.
The main types of panic attack treatment include cognitive behavioral therapy (CBT), medications, and other approaches. CBT is a structured, time-limited psychotherapy that helps individuals recognize and modify negative thought patterns and behaviors that contribute to anxiety and panic episodes. Medications used include antidepressants, anti-anxiety drugs, calcitonin gene-related peptide (CGRP) antagonists, and others. These medications are administered via oral, intravenous, intramuscular, sublingual, and other routes, and are distributed through hospital pharmacies, retail pharmacies, and online pharmacies. They are applied in settings such as hospitals, mental healthcare centers, and other healthcare facilities.
The panic attack treatment market consists of revenues earned by entities by providing services such as exposure therapy sessions, dialectical behavior therapy, telepsychiatry and remote consultation services, mental wellness subscription platforms, supportive counseling and peer group therapy, and personalized mental health coaching. The market value includes the value of related goods sold by the service provider or included within the service offering. The panic attack treatment market also includes sales of biofeedback and neurofeedback devices, virtual reality-based therapy solutions, mobile mental health applications, genetic testing kits for psychiatric profiling, mental health diagnostic and screening tools, wearable devices for anxiety monitoring, AI-powered therapeutic chatbots, and digital therapeutic platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Panic Attack Treatment Market Characteristics
3. Panic Attack Treatment Market Supply Chain Analysis
4. Global Panic Attack Treatment Market Trends and Strategies
5. Panic Attack Treatment Market Analysis of End Use Industries
7. Global Panic Attack Treatment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Panic Attack Treatment Total Addressable Market (TAM) Analysis for the Market
9. Panic Attack Treatment Market Segmentation
10. Panic Attack Treatment Market Regional and Country Analysis
11. Asia-Pacific Panic Attack Treatment Market
12. China Panic Attack Treatment Market
13. India Panic Attack Treatment Market
14. Japan Panic Attack Treatment Market
15. Australia Panic Attack Treatment Market
16. Indonesia Panic Attack Treatment Market
17. South Korea Panic Attack Treatment Market
18. Taiwan Panic Attack Treatment Market
19. South East Asia Panic Attack Treatment Market
20. Western Europe Panic Attack Treatment Market
21. UK Panic Attack Treatment Market
22. Germany Panic Attack Treatment Market
23. France Panic Attack Treatment Market
24. Italy Panic Attack Treatment Market
25. Spain Panic Attack Treatment Market
26. Eastern Europe Panic Attack Treatment Market
27. Russia Panic Attack Treatment Market
28. North America Panic Attack Treatment Market
29. USA Panic Attack Treatment Market
30. Canada Panic Attack Treatment Market
31. South America Panic Attack Treatment Market
32. Brazil Panic Attack Treatment Market
33. Middle East Panic Attack Treatment Market
34. Africa Panic Attack Treatment Market
36. Panic Attack Treatment Market Competitive Landscape and Company Profiles
37. Panic Attack Treatment Market Other Major and Innovative Companies
40. Panic Attack Treatment Market High Potential Countries, Segments and Strategies
41. Appendix
Executive Summary
Panic Attack Treatment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses panic attack treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for panic attack treatment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The panic attack treatment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Treatment Type: Cognitive Behavioral Therapy (CBT); Medications; Other Treatment Types2) By Drug Class: Antidepressants; Anti-Anxiety Drugs; Calcitonin Gene-Related Peptide (CGRP) Antagonists; Other Drug Classes
3) By Route Of Administration: Oral; Sublingual; Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
5) By Application: Hospitals; Mental Healthcare Centers; Other Applications
Subsegments:
1) By Cognitive Behavioral Therapy (CBT): Exposure Therapy; Dialectical Behavior Therapy (DBT); Acceptance And Commitment Therapy (ACT); Mindfulness-Based Cognitive Therapy (MBCT); Rational Emotive Behavior Therapy (REBT)2) By Medications: Beta Blockers; Buspirone; Anticonvulsants; Atypical Antipsychotics; Herbal And Natural Supplements
3) By Other Treatment Types: Telepsychiatry; Biofeedback And Neurofeedback; Virtual Reality Therapy; Mobile Health Applications; Support Groups And Counseling Services
Companies Mentioned: Pfizer Inc.; Johnson & Johnson Services Inc.; F. Hoffmann‑La Roche Ltd.; Sanofi S.A.; AstraZeneca Plc; Novartis AG; GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Viatris Inc.; Teva Pharmaceutical Industries Ltd.; Sun Pharmaceutical Industries Ltd.; Sumitomo Dainippon Pharma; Lundbeck A/S; Torrent Pharmaceuticals Ltd.; Merck & Co Inc.; Bristol‑Myers Squibb Company; Otsuka Pharmaceutical Co Ltd; Boehringer Ingelheim International GmbH; Allergan plc; Alkermes plc; Jazz Pharmaceuticals plc; Bayer AG; Amgen Inc.; Cipla Limited
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Panic Attack Treatment market report include:- Pfizer Inc.
- Johnson & Johnson Services Inc.
- F. Hoffmann‑La Roche Ltd.
- Sanofi S.A.
- AstraZeneca Plc
- Novartis AG
- GlaxoSmithKline plc
- Takeda Pharmaceutical Company Limited
- Eli Lilly and Company
- Viatris Inc.
- Teva Pharmaceutical Industries Ltd.
- Sun Pharmaceutical Industries Ltd.
- Sumitomo Dainippon Pharma
- Lundbeck A/S
- Torrent Pharmaceuticals Ltd.
- Merck & Co Inc.
- Bristol‑Myers Squibb Company
- Otsuka Pharmaceutical Co Ltd
- Boehringer Ingelheim International GmbH
- Allergan plc
- Alkermes plc
- Jazz Pharmaceuticals plc
- Bayer AG
- Amgen Inc.
- Cipla Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 4.21 Billion |
| Forecasted Market Value ( USD | $ 7.97 Billion |
| Compound Annual Growth Rate | 17.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 26 |
